CIK 0001367083
- Non-accelerated filer
- Smaller reporting company
Sonoma Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SNOA
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680423298
- Phone
- +1 800-759-9305
- Business address
- 5445 CONESTOGA COURT, SUITE 150, BOULDER, CO, 80301
- Former names
- Oculus Innovative Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-19 | Thornton Bruce Executive VP and COO | Grant or award · Restricted Stock Units | +13,500 | 32,191 | ||
| 2025-01-02 | Thornton Bruce Executive VP & COO | Grant or award · Restricted Stock Units | +10,000 | 18,691 | ||
| 2024-06-20 | Thornton Bruce Executive Vice President | Grant or award | +53,586 | 154,411 | ||
| 2023-12-29 | Thornton Bruce Executive VP & COO | Grant or award · Stock option (right to buy) | +60,000 | 176,781 | ||
| 2023-06-30 | Thornton Bruce Executive Vice President | Grant or award | +100,000 | 216,781 | ||
| 2022-12-29 | Thornton Bruce Chief Operating Officer | Grant or award · Stock option (right to buy) | +40,000 | 116,781 | ||
| 2022-01-14 | Thornton Bruce COO | Grant or award · Stock option (right to buy) | +30,000 | 76,781 | ||
| 2021-01-07 | Thornton Bruce COO | Grant or award · Stock option (right to buy) | +27,777 | 47,377 | ||
| 2007-06-15 | Thornton Bruce Vice President | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 |
Page 1 of 1 · 9 trades